Viewing Study NCT03558750

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2026-01-04 @ 4:56 PM
Study NCT ID: NCT03558750
Status: TERMINATED
Last Update Posted: 2019-04-25
First Post: 2018-06-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma
Sponsor: Vanderbilt-Ingram Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Central Nervous System Lymphoma View
None Recurrent Diffuse Large B-Cell Lymphoma View
None Refractory Central Nervous System Lymphoma View
None Refractory Diffuse Large B-Cell Lymphoma View
Keywords: